Tiotropium bromide is a long-acting anticholinergic bronchodilator used for long-term maintenance therapy in patients with stable chronic obstructive pulmonary disease, requiring long-term inhalation, which can dilate the bronchial tubes, alleviate the symptoms of shortness of breath in patients with chronic obstructive pulmonary disease, and help to reduce the acute exacerbation of chronic obstructive pulmonary disease, and it is often combined with inhaled glucocorticoids. Chronic obstructive pulmonary disease is characterized by incomplete reversible airflow limitation, is a preventable and treatable chronic inflammatory disease of the airways, patients with chronic obstructive pulmonary disease can be maintained for a long period of time by adhering to the medication during the stabilization period. The disease may progress to a certain degree with each acute exacerbation of chronic obstructive pulmonary disease, so patients with chronic obstructive pulmonary disease need to adhere to the medication through the long-term regularity to achieve long-term stabilization. Long-term medications for patients with chronic obstructive pulmonary disease mainly include bronchodilators such as tiotropium bromide and glucocorticosteroids such as budesonide inhaler to maintain a stable state, thus improving the prognosis. Chronic obstructive pulmonary disease is a chronic disease that can be prevented and treated, patients are advised to visit the hospital in time and actively diagnose and treat the disease to avoid delay. The above medications should be used in a standardized manner under the guidance of a doctor, and should not be used on their own.